These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 29067094)
1. Dasatinib and chemotherapy in a patient with early T-cell precursor acute lymphoblastic leukemia and Chen Y; Zhang L; Huang J; Hong X; Zhao J; Wang Z; Zhang K Exp Ther Med; 2017 Nov; 14(5):3979-3984. PubMed ID: 29067094 [TBL] [Abstract][Full Text] [Related]
2. Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies. Quintás-Cardama A; Tong W; Manshouri T; Vega F; Lennon PA; Cools J; Gilliland DG; Lee F; Cortes J; Kantarjian H; Garcia-Manero G Leukemia; 2008 Jun; 22(6):1117-24. PubMed ID: 18401417 [TBL] [Abstract][Full Text] [Related]
3. NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins. De Keersmaecker K; Porcu M; Cox L; Girardi T; Vandepoel R; de Beeck JO; Gielen O; Mentens N; Bennett KL; Hantschel O Haematologica; 2014 Jan; 99(1):85-93. PubMed ID: 23872305 [TBL] [Abstract][Full Text] [Related]
4. Case Report: The First Report of Wang HP; He JJ; Zhu QY; Wang L; Li JH; Huang JS; Xie WZ; Zhu HH; Jin J Front Oncol; 2021; 11():706798. PubMed ID: 34307175 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy. Nardi V; McAfee SL; Dal Cin P; Tsai HK; Amrein PC; Hobbs GS; Brunner AM; Narayan R; Foster J; Fathi AT; Hock H Oncologist; 2022 Mar; 27(2):82-86. PubMed ID: 35641210 [TBL] [Abstract][Full Text] [Related]
6. Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis. Chiaretti S; Tavolaro S; Ghia EM; Ariola C; Matteucci C; Elia L; Maggio R; Messina M; Ricciardi MR; Vitale A; Ritz J; Mecucci C; Guarini A; Foà R Haematologica; 2007 May; 92(5):619-26. PubMed ID: 17488685 [TBL] [Abstract][Full Text] [Related]
7. ABL1 fusions in T-cell acute lymphoblastic leukemia. De Keersmaecker K Verh K Acad Geneeskd Belg; 2008; 70(4):245-55. PubMed ID: 19166098 [TBL] [Abstract][Full Text] [Related]
12. Xu X; Zhai Q; Jin H; Yu Y; Han D; Zhang H; Fu K; Meng B Int J Gen Med; 2021; 14():659-664. PubMed ID: 33658838 [TBL] [Abstract][Full Text] [Related]
13. Intrinsic differences between the catalytic properties of the oncogenic NUP214-ABL1 and BCR-ABL1 fusion protein kinases. De Keersmaecker K; Versele M; Cools J; Superti-Furga G; Hantschel O Leukemia; 2008 Dec; 22(12):2208-16. PubMed ID: 18784740 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia. Graux C; Stevens-Kroef M; Lafage M; Dastugue N; Harrison CJ; Mugneret F; Bahloula K; Struski S; Grégoire MJ; Nadal N; Lippert E; Taviaux S; Simons A; Kuiper RP; Moorman AV; Barber K; Bosly A; Michaux L; Vandenberghe P; Lahortiga I; De Keersmaecker K; Wlodarska I; Cools J; Hagemeijer A; Poirel HA; ; Leukemia; 2009 Jan; 23(1):125-33. PubMed ID: 18923437 [TBL] [Abstract][Full Text] [Related]
15. Detection of a cryptic Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Koon SJ; Webley MR; McGrath M; Bayerl MG; Baughn LB; Rowsey RA; Ketterling RP; Greipp PT; Hoppman NL Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936193 [TBL] [Abstract][Full Text] [Related]
16. Clinico-Hematological Profile and Copy Number Abnormalities in a Cohort of Patra N; Singh M; Sharma P; Trehan A; Naseem S; Bansal D; Bhatia P Indian J Hematol Blood Transfus; 2021 Oct; 37(4):555-562. PubMed ID: 34744339 [TBL] [Abstract][Full Text] [Related]
17. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome. Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836 [TBL] [Abstract][Full Text] [Related]
18. Response to single agent dasatinib post allogeneic transplant in B-cell acute lymphoblastic leukemia with Aldoss I; Pullarkat V Leuk Lymphoma; 2019 Nov; 60(11):2832-2834. PubMed ID: 31014138 [No Abstract] [Full Text] [Related]
19. Choi YJ; Min YK; Lee ST; Choi JR; Shin S Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892 [TBL] [Abstract][Full Text] [Related]
20. Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia. Koka R; Bade NA; Sausville EA; Ning Y; Zou Y Mol Cytogenet; 2017; 10():39. PubMed ID: 29093755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]